Loading...

FITC anti-mouse/human CD44 Antibody FITC anti-mouse/human CD44 Antibody

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7
C57BL/6 splenocytes stained with IM7 FITC
  • IM7
    C57BL/6 splenocytes stained with IM7 FITC
  • IM7_FITC_060710
    Human peripheral blood lymphocytes stained with IM7 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103021 25 tests DKK250
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103005 50 µg DKK280
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103006 500 µg DKK654
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103022 100 tests DKK666
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
µg sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
µg sizes: 0.5 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The CD44 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the µg size, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  2. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  3. Fan NW, et al. 2023. FASEB J. 37:e22855. PubMed
  4. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  5. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  6. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  7. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
  8. Wang S, et al. 2019. Int J Oncol. 54:966. PubMed
  9. Yang L, et al. 2022. Front Oncol. 12:862250. PubMed
  10. Goncharov NV, et al. 2022. J Evol Biochem Physiol. 58:230. PubMed
  11. Qu L, et al. 2022. Cell. 185:1728. PubMed
  12. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  13. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  14. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  15. Yang L, et al. 2023. JCI Insight. 8: . PubMed
  16. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  17. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  18. Ye ZW, et al. 2022. Cell Mol Immunol. 19:588. PubMed
  19. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  20. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  21. Israelow B, et al. 2020. bioRxiv. . PubMed
  22. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  23. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
  24. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  25. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  26. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  27. Dong L, et al. 2021. Cancer Cell. . PubMed
  28. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  29. Wang D, et al. 2018. Immunity. 48:659. PubMed
  30. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  31. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  32. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  33. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  34. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  35. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  36. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  37. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  38. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  39. Hao J et al. 2018. Cell metabolism. 28(5):689-705 . PubMed
  40. Diao L, et al. 2022. iScience. 25:105511. PubMed
  41. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  42. Kmieciak M, et al. 2011. Breast Cancer Res Treat. 126:385. PubMed
  43. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  44. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  45. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  46. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  47. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  48. Bagheri V et al. 2018. Journal of cellular physiology. 233(10):7036-7046 . PubMed
  49. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  50. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  51. Yang L, et al. 2021. JCI Insight. 6:. PubMed
  52. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  53. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  54. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  55. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  56. Murai T, et al. 2013. J Cell Sci. 126:3284. PubMed
  57. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  58. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  59. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  60. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  61. Wang Z, et al. 2022. Ann Transl Med. 10:544. PubMed
  62. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  63. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  64. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  65. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  66. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  67. Amici SA, et al. 2021. Front Immunol. 12:695947. PubMed
  68. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  69. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  70. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  71. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  72. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  73. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  74. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  75. Xia H, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L926. PubMed
  76. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  77. Wan X, et al. 2018. Nature. 560:107. PubMed
  78. Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed
  79. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  80. Wu X, et al. 2022. Cell Death Dis. 13:557. PubMed
  81. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  82. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  83. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  84. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  85. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  86. Ahmed MF, et al. 2019. Exp Ther Med. 17:4154. PubMed
  87. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  88. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  89. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  90. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  91. Liu ZZ, et al. 2021. Autophagy. 17:2766. PubMed
  92. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  93. Liu Z, et al. 2016. Sci Rep. 6:34416. PubMed
  94. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  95. Kamijo S, et al. 2013. J Immunol. 190:4489. PubMed
  96. Pham D, et al. 2019. Cell Rep. 29:1203. PubMed
  97. Matossian MD, et al. 2019. BMC Cancer. 19:205. PubMed
  98. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  99. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  100. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  101. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  102. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  103. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  104. Geburek F, et al. 2017. Stem Cell Res Ther. 8:129. PubMed
  105. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  106. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  107. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  108. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  109. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  110. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  111. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  112. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  113. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  114. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  115. Witschen PM, et al. 2020. Cancers. 12(5):1325. PubMed
  116. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  117. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  118. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  119. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  120. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  121. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  122. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  123. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  124. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  125. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  126. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  127. Graham JB, et al. 2017. Curr Protoc Mouse Biol. 7:221. PubMed
  128. Burl RB et al. 2018. Cell metabolism. 28(2):300-309 . PubMed
  129. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  130. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  131. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  132. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  133. Yang L, et al. 2022. Proteomics. 22:e2200018. PubMed
  134. Bi R, et al. 2020. Osteoarthritis Cartilage. 28:842. PubMed
  135. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  136. Zhao Y, et al. 2020. Br J Cancer. 1638:122. PubMed
  137. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  138. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
  139. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  140. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  141. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  142. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  143. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  144. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  145. Fan NW, et al. 2023. FASEB J. 37:e22855. PubMed
  146. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  147. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  148. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  149. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
  150. Wang S, et al. 2019. Int J Oncol. 54:966. PubMed
  151. Yang L, et al. 2022. Front Oncol. 12:862250. PubMed
  152. Goncharov NV, et al. 2022. J Evol Biochem Physiol. 58:230. PubMed
  153. Qu L, et al. 2022. Cell. 185:1728. PubMed
  154. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  155. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  156. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  157. Yang L, et al. 2023. JCI Insight. 8: . PubMed
  158. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  159. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  160. Ye ZW, et al. 2022. Cell Mol Immunol. 19:588. PubMed
  161. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  162. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  163. Israelow B, et al. 2020. bioRxiv. . PubMed
  164. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  165. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
  166. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  167. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  168. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  169. Dong L, et al. 2021. Cancer Cell. . PubMed
  170. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  171. Wang D, et al. 2018. Immunity. 48:659. PubMed
  172. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  173. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  174. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  175. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  176. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  177. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  178. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  179. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  180. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  181. Hao J et al. 2018. Cell metabolism. 28(5):689-705 . PubMed
  182. Diao L, et al. 2022. iScience. 25:105511. PubMed
  183. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  184. Kmieciak M, et al. 2011. Breast Cancer Res Treat. 126:385. PubMed
  185. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  186. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  187. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  188. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  189. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  190. Bagheri V et al. 2018. Journal of cellular physiology. 233(10):7036-7046 . PubMed
  191. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  192. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  193. Yang L, et al. 2021. JCI Insight. 6:. PubMed
  194. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  195. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  196. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  197. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  198. Murai T, et al. 2013. J Cell Sci. 126:3284. PubMed
  199. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  200. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  201. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  202. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  203. Wang Z, et al. 2022. Ann Transl Med. 10:544. PubMed
  204. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  205. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  206. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  207. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  208. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  209. Amici SA, et al. 2021. Front Immunol. 12:695947. PubMed
  210. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  211. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  212. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  213. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  214. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  215. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  216. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  217. Xia H, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L926. PubMed
  218. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  219. Wan X, et al. 2018. Nature. 560:107. PubMed
  220. Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed
  221. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  222. Wu X, et al. 2022. Cell Death Dis. 13:557. PubMed
  223. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  224. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  225. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  226. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  227. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  228. Ahmed MF, et al. 2019. Exp Ther Med. 17:4154. PubMed
  229. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  230. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  231. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  232. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  233. Liu ZZ, et al. 2021. Autophagy. 17:2766. PubMed
  234. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  235. Liu Z, et al. 2016. Sci Rep. 6:34416. PubMed
  236. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  237. Kamijo S, et al. 2013. J Immunol. 190:4489. PubMed
  238. Pham D, et al. 2019. Cell Rep. 29:1203. PubMed
  239. Matossian MD, et al. 2019. BMC Cancer. 19:205. PubMed
  240. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  241. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  242. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  243. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  244. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  245. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  246. Geburek F, et al. 2017. Stem Cell Res Ther. 8:129. PubMed
  247. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  248. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  249. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  250. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  251. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  252. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  253. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  254. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  255. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  256. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  257. Witschen PM, et al. 2020. Cancers. 12(5):1325. PubMed
  258. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  259. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  260. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  261. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  262. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  263. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  264. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  265. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  266. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  267. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  268. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  269. Graham JB, et al. 2017. Curr Protoc Mouse Biol. 7:221. PubMed
  270. Burl RB et al. 2018. Cell metabolism. 28(2):300-309 . PubMed
  271. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  272. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  273. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  274. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  275. Yang L, et al. 2022. Proteomics. 22:e2200018. PubMed
  276. Bi R, et al. 2020. Osteoarthritis Cartilage. 28:842. PubMed
  277. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  278. Zhao Y, et al. 2020. Br J Cancer. 1638:122. PubMed
  279. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  280. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
  281. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  282. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  283. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  284. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
RRID
AB_493684 (BioLegend Cat. No. 103021)
AB_312956 (BioLegend Cat. No. 103005)
AB_312957 (BioLegend Cat. No. 103006)
AB_493685 (BioLegend Cat. No. 103022)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
APC anti-mouse/human CD44 IM7 FC
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
PE anti-mouse/human CD44 IM7 FC
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
PE/Fire™ 810 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark YG™ 581 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark NIR™ 685 anti-mouse/human CD44 (Flexi-Fluor™) Antibody IM7 FC
Spark UV™ 387 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
StarBright UltraViolet 795 anti-mouse/human CD44 IM7 FC
Go To Top Version: 2    Revision Date: 09/11/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7
C57BL/6 splenocytes stained with IM7 FITC
  • IM7
    C57BL/6 splenocytes stained with IM7 FITC
  • IM7_FITC_060710
    Human peripheral blood lymphocytes stained with IM7 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103021 25 tests DKK250
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103005 50 µg DKK280
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103006 500 µg DKK654
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103022 100 tests DKK666
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
µg sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
µg sizes: 0.5 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The CD44 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the µg size, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  2. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  3. Fan NW, et al. 2023. FASEB J. 37:e22855. PubMed
  4. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  5. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  6. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  7. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
  8. Wang S, et al. 2019. Int J Oncol. 54:966. PubMed
  9. Yang L, et al. 2022. Front Oncol. 12:862250. PubMed
  10. Goncharov NV, et al. 2022. J Evol Biochem Physiol. 58:230. PubMed
  11. Qu L, et al. 2022. Cell. 185:1728. PubMed
  12. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  13. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  14. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  15. Yang L, et al. 2023. JCI Insight. 8: . PubMed
  16. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  17. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  18. Ye ZW, et al. 2022. Cell Mol Immunol. 19:588. PubMed
  19. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  20. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  21. Israelow B, et al. 2020. bioRxiv. . PubMed
  22. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  23. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
  24. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  25. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  26. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  27. Dong L, et al. 2021. Cancer Cell. . PubMed
  28. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  29. Wang D, et al. 2018. Immunity. 48:659. PubMed
  30. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  31. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  32. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  33. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  34. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  35. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  36. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  37. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  38. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  39. Hao J et al. 2018. Cell metabolism. 28(5):689-705 . PubMed
  40. Diao L, et al. 2022. iScience. 25:105511. PubMed
  41. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  42. Kmieciak M, et al. 2011. Breast Cancer Res Treat. 126:385. PubMed
  43. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  44. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  45. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  46. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  47. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  48. Bagheri V et al. 2018. Journal of cellular physiology. 233(10):7036-7046 . PubMed
  49. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  50. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  51. Yang L, et al. 2021. JCI Insight. 6:. PubMed
  52. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  53. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  54. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  55. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  56. Murai T, et al. 2013. J Cell Sci. 126:3284. PubMed
  57. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  58. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  59. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  60. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  61. Wang Z, et al. 2022. Ann Transl Med. 10:544. PubMed
  62. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  63. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  64. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  65. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  66. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  67. Amici SA, et al. 2021. Front Immunol. 12:695947. PubMed
  68. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  69. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  70. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  71. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  72. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  73. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  74. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  75. Xia H, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L926. PubMed
  76. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  77. Wan X, et al. 2018. Nature. 560:107. PubMed
  78. Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed
  79. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  80. Wu X, et al. 2022. Cell Death Dis. 13:557. PubMed
  81. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  82. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  83. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  84. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  85. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  86. Ahmed MF, et al. 2019. Exp Ther Med. 17:4154. PubMed
  87. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  88. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  89. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  90. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  91. Liu ZZ, et al. 2021. Autophagy. 17:2766. PubMed
  92. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  93. Liu Z, et al. 2016. Sci Rep. 6:34416. PubMed
  94. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  95. Kamijo S, et al. 2013. J Immunol. 190:4489. PubMed
  96. Pham D, et al. 2019. Cell Rep. 29:1203. PubMed
  97. Matossian MD, et al. 2019. BMC Cancer. 19:205. PubMed
  98. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  99. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  100. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  101. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  102. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  103. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  104. Geburek F, et al. 2017. Stem Cell Res Ther. 8:129. PubMed
  105. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  106. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  107. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  108. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  109. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  110. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  111. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  112. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  113. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  114. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  115. Witschen PM, et al. 2020. Cancers. 12(5):1325. PubMed
  116. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  117. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  118. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  119. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  120. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  121. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  122. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  123. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  124. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  125. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  126. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  127. Graham JB, et al. 2017. Curr Protoc Mouse Biol. 7:221. PubMed
  128. Burl RB et al. 2018. Cell metabolism. 28(2):300-309 . PubMed
  129. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  130. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  131. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  132. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  133. Yang L, et al. 2022. Proteomics. 22:e2200018. PubMed
  134. Bi R, et al. 2020. Osteoarthritis Cartilage. 28:842. PubMed
  135. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  136. Zhao Y, et al. 2020. Br J Cancer. 1638:122. PubMed
  137. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  138. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
  139. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  140. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  141. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  142. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  143. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  144. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  145. Fan NW, et al. 2023. FASEB J. 37:e22855. PubMed
  146. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  147. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  148. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  149. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
  150. Wang S, et al. 2019. Int J Oncol. 54:966. PubMed
  151. Yang L, et al. 2022. Front Oncol. 12:862250. PubMed
  152. Goncharov NV, et al. 2022. J Evol Biochem Physiol. 58:230. PubMed
  153. Qu L, et al. 2022. Cell. 185:1728. PubMed
  154. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  155. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  156. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  157. Yang L, et al. 2023. JCI Insight. 8: . PubMed
  158. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  159. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  160. Ye ZW, et al. 2022. Cell Mol Immunol. 19:588. PubMed
  161. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  162. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  163. Israelow B, et al. 2020. bioRxiv. . PubMed
  164. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  165. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
  166. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  167. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  168. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  169. Dong L, et al. 2021. Cancer Cell. . PubMed
  170. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  171. Wang D, et al. 2018. Immunity. 48:659. PubMed
  172. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  173. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  174. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  175. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  176. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  177. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  178. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  179. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  180. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  181. Hao J et al. 2018. Cell metabolism. 28(5):689-705 . PubMed
  182. Diao L, et al. 2022. iScience. 25:105511. PubMed
  183. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  184. Kmieciak M, et al. 2011. Breast Cancer Res Treat. 126:385. PubMed
  185. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  186. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  187. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  188. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  189. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  190. Bagheri V et al. 2018. Journal of cellular physiology. 233(10):7036-7046 . PubMed
  191. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  192. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  193. Yang L, et al. 2021. JCI Insight. 6:. PubMed
  194. Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed
  195. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  196. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  197. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  198. Murai T, et al. 2013. J Cell Sci. 126:3284. PubMed
  199. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  200. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  201. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  202. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  203. Wang Z, et al. 2022. Ann Transl Med. 10:544. PubMed
  204. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  205. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  206. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  207. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  208. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  209. Amici SA, et al. 2021. Front Immunol. 12:695947. PubMed
  210. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  211. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  212. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  213. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  214. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  215. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  216. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  217. Xia H, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L926. PubMed
  218. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  219. Wan X, et al. 2018. Nature. 560:107. PubMed
  220. Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed
  221. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  222. Wu X, et al. 2022. Cell Death Dis. 13:557. PubMed
  223. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  224. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  225. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  226. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  227. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  228. Ahmed MF, et al. 2019. Exp Ther Med. 17:4154. PubMed
  229. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  230. Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
  231. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  232. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  233. Liu ZZ, et al. 2021. Autophagy. 17:2766. PubMed
  234. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  235. Liu Z, et al. 2016. Sci Rep. 6:34416. PubMed
  236. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  237. Kamijo S, et al. 2013. J Immunol. 190:4489. PubMed
  238. Pham D, et al. 2019. Cell Rep. 29:1203. PubMed
  239. Matossian MD, et al. 2019. BMC Cancer. 19:205. PubMed
  240. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  241. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  242. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  243. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  244. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  245. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  246. Geburek F, et al. 2017. Stem Cell Res Ther. 8:129. PubMed
  247. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  248. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  249. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  250. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  251. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  252. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  253. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  254. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  255. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  256. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  257. Witschen PM, et al. 2020. Cancers. 12(5):1325. PubMed
  258. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  259. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  260. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  261. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  262. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  263. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  264. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  265. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  266. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  267. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  268. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  269. Graham JB, et al. 2017. Curr Protoc Mouse Biol. 7:221. PubMed
  270. Burl RB et al. 2018. Cell metabolism. 28(2):300-309 . PubMed
  271. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  272. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  273. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  274. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  275. Yang L, et al. 2022. Proteomics. 22:e2200018. PubMed
  276. Bi R, et al. 2020. Osteoarthritis Cartilage. 28:842. PubMed
  277. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  278. Zhao Y, et al. 2020. Br J Cancer. 1638:122. PubMed
  279. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  280. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
  281. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  282. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  283. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  284. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
RRID
AB_493684 (BioLegend Cat. No. 103021)
AB_312956 (BioLegend Cat. No. 103005)
AB_312957 (BioLegend Cat. No. 103006)
AB_493685 (BioLegend Cat. No. 103022)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
APC anti-mouse/human CD44 IM7 FC
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
PE anti-mouse/human CD44 IM7 FC
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
PE/Fire™ 810 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark YG™ 581 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark NIR™ 685 anti-mouse/human CD44 (Flexi-Fluor™) Antibody IM7 FC
Spark UV™ 387 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
StarBright UltraViolet 795 anti-mouse/human CD44 IM7 FC
Go To Top Version: 2    Revision Date: 09/11/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account